Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)
- Resource Type
- Article
- Source
- In
eClinicalMedicine December 2023 66 - Subject
- Language
- ISSN
- 2589-5370